For the first time in three decades, the American Academy of Pediatrics is substantially diverging from U.S. government ...

Experts also recommend staying up-to-date on vaccines for the flu, COVID-19 and RSV. Trump administration revokes security ...

COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.

Routine screening, early detection, and prompt treatment of infections can help limit spread, and non-mRNA options like viral vector vaccines can strengthen population immunity.

He’s using Biden-era mistakes to tarnish a promising technology.

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...

A rare immune disorder has inspired a potential universal antiviral therapy. By mimicking the mutation s unique inflammation signature, researchers developed an mRNA-based treatment that stopped ...

Following the criticism of mRNA vaccine strategies by federal leaders, UNC Health's Dr. David Wohl shared why he supports the research.

Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...

Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...

She and her husband, Steve, and their kids were all sickened by the virus four years ago, with different symptoms and degrees ...